Sign Out
a.) Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
b.) Extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy.
c.) First and second line treatment of postmenopausal women hormone-receptor positive or unknown advanced breast cancer.
